Globus Medical (GMED) Tops Q1 EPS by 1c

Globus Medical (NYSE: GMED) reported Q1 EPS of $0.29, $0.01 better than the analyst estimate of $0.28. Revenue for the quarter came in at $139.3 million versus the consensus estimate of $140.3 million.

Globus Medical reaffirmed FY2016 guidance.

For earnings history and earnings-related data on Globus Medical (GMED) click here.

You May Also Be Interested In

• United Natural Foods (UNFI) Tops Q4 EPS by 8c ; Offers Guidance
• Morgan Stanley upgrades Synopsys as it turns selective on chip stocks
• Bernstein SocGen Group Reiterates Outperform Rating on Robinhood Markets (HOOD)